Researchers demonstrated approximately 3-fold higher doxorubicin internalization in inflammatory breast cancer cells compared to healthy breast epithelial cells, leading to targeted cell death at concentrations below the IC50 of free doxorubicin.
[Journal of the American Chemical Society]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
171964
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
